NetworkNewsBreaks – FinCanna Capital Corp. (CSE:
Post# of 30

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company, Refined Resin Technologies Inc., has secured its first purchase order for THC distillate in the amount of $840,000. The purchase order received from a high volume, top California cannabis brand specified $840,000 as the minimum annual amount. Monthly volumes and the related payments may increase based on reliable delivery and performance. “To secure a large purchase order from a top California brand is a testament to the stature of the Refined Resin team and bodes well for future demand,” FinCanna Capital President and CEO Andriyko Herchak stated in the news release. “Refined Resin’s principals have extensive experience in extraction, manufacturing, business operations and marketing that is evidenced by their ability to obtain an order of this size while still completing their production facility. This accomplishment is a clear demonstration of their ability to grow a lucrative business which should be highly rewarding for the Refined team and our FinCanna shareholders.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

